ArticleJGH open : an open access journal of gastroenterology and hepatology2021

Clinical response of vedolizumab at week 6 predicted endoscopic remission at week 24 in ulcerative colitis.

Daisuke Saito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.